Metabolic medicines
GW0742
A PPAR-beta/delta research agonist with mouse metabolic findings and no established human performance benefit in these sources.
Preclinical mouse research
Practical use
Reviewed practical notes
- Check the identifier
- GW0742 and GW501516 are separate molecules.
- Keep the model visible
- These are animal experiments, not clinical efficacy trials.
- Avoid combination extrapolation
- A laboratory combination does not provide a human drug-use protocol.
Overview
GW0742 activates the nuclear receptor PPAR-beta/delta, which helps regulate metabolic gene expression. It is a different compound from GW501516, also called GW1516. Similar target activity does not make their experiments, toxicology or identities interchangeable.
Risks and limitations
The reviewed experiments do not establish human safety, a therapeutic indication or a reliable benefit for athletes. They also cannot authenticate products sold under the research name. Apparent improvement in a mouse metabolic marker is not an adequate safety assessment.
How to read this
These studies ask how exercise, diet change and receptor activation interact. They are useful mechanistic experiments, but several interventions often change at once. That makes a headline claiming a drug replaces exercise particularly misleading.
Research explained
Diet change, exercise and GW0742 in obese mice
Who was studied
24 female mice with diet-induced obesity, assigned to four groups during an eight-week intervention after switching diets.
What was found
Researchers observed changes in immune and metabolic markers, with some effects greater when exercise and receptor activation were combined.
What it cannot establish
Small animal groups and a changing diet limit attribution. Human athletic outcomes, chronic safety and clinical benefit were not tested.
Read the original studyCombined pathway activation during training
Who was studied
Trained mice studied with AICAR and GW0742 in an experimental endurance setting.
What was found
Combined pathway activation was associated with altered energy-substrate use and greater endurance-related effects.
What it cannot establish
A combination experiment cannot establish the independent effect of GW0742 or justify combining research drugs in people.
Read the original studyThe comparison determines the claim
A trained mouse receiving multiple interventions is not a test of an untrained person taking one compound. Check which groups were compared before attributing an outcome to GW0742 alone.
Supporting sourceSources
2016 combined-pathway mouse study
Sources checked 2026-10-01.
General education; not a personal treatment plan.